Post

Solaiman Erfan
Solaiman Erfan
$INJ just got a serious narrative upgrade. $INJ is up 56% in 30 days, but the bigger story is happening beyond the chart. Two U.S. spot INJ ETF applications are under SEC review, and Injective’s CEO now expects them before 2027. Add its new institutional infrastructure and tokenized-asset push. Momentum + regulation + RWA narrative. Is $INJ becoming one of October’s sleepers? 👀
INJUSDTPerp50xBuyOpen position
Trade
Snapshot at Oct 06, 2026, 04:43

Disclaimer: OKX Orbit content is provided for informational purposes only. Learn more

Replies

No comments yet. Be the first to reply!